|
Match
|
Document |
Document Title |
|
|
7541022 |
Pharmaceutical formulations for dry powder inhalers
A powder for use in a dry powder inhaler comprises: i) a fraction n of fine particle size constituted by a mixture of physiologically acceptable excipient and an additive; ii) a fraction of coarse...
|
|
|
7541050 |
Two-layered olefin-based resin pellets for insecticidal resin composition
A two-layered olefin-based resin pellet comprising a core layer formed of an olefin-based resin composition (A) and a sheath layer formed of an olefin-based resin composition (B) and laminated on...
|
|
|
7537787 |
Method for modulating glutamate and/or aspartate release in a central nervous system locus
Methods and compositions are disclosed for providing prolonged-release of therapeutic agents by way of in situ stereotaxic implantation in specific loci, including pathways, to treat know...
|
|
|
7537785 |
Composition for treating vascular diseases characterized by nitric oxide insufficiency
The present invention provides a composition comprising an antioxidant, and at least one of isosorbide dinitrate and isosorbide mononitrate in therapeutically effective dosage of each of the...
|
|
|
7537786 |
Complex of drug-carbon nanohorn and a process for producing the complex
The present invention provides a carbon nanohorn complex that is excellent in characteristics of adsorption or inclusion of drugs and release, in particular, a sustained release of drugs as a novel...
|
|
|
7531191 |
Stimuli-responsive systems for controlled drug delivery
A method of delivering a therapeutic agent by providing a cross-linked polymer encapsulating the therapeutic agent to a site in a patient. The degradation rate of the cross-linked polymer is...
|
|
|
7531500 |
Preventing airway mucus production by administration of EGF-R antagonists
Hypersecretion of mucus in the lungs is inhibited by the administration of an epidermal growth factor receptor (EGF-R) antagonist. The EGF-R antagonist may be in the form of a small organic...
|
|
|
7531184 |
Composite powders and cosmetics containing the same
A composite powder containing a powdery base and aluminum hydroxide adhered to at least a portion of the surface of the base, wherein said adhered aluminum hydroxide in the form of a spherical and...
|
|
|
7527809 |
Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof
A structure containing polyhydroxyalkanoate and a magnetic substance includes an external phase part containing polyhydroxyalkanoate and an internal phase part contained in the external phase part,...
|
|
|
7527808 |
Amorphous cefditoren pivoxil composition and process for producing the same
An objective of the present invention is to provide an amorphous cefditoren pivoxil composition possessing excellent stability and dissolvability and to provide a production process of the...
|
|
|
7524484 |
Delivery of diphenhydramine through an inhalation route
The present invention relates to the delivery of diphenhydramine through an inhalation route. In a composition aspect of the present invention, a composition of a diphenhydramine condensation...
|
|
|
7524515 |
Pharmaceutical safety dosage forms
Pharmaceutical safety dosage forms are provided which include a pharmaceutical and an antagonist to the pharmaceutical. The safety dosage forms are such that the antagonist has no significant...
|
|
|
7524560 |
Enhanced boron nitride composition and compositions made therewith
A boron nitride composition having its surface treated with a coating layer comprising at least one of a silane, a siloxane, a carboxylic derivative, and mixtures thereof, wherein the coating layer...
|
|
|
7521070 |
Agent for preventing and curing pathologies states associated with endorphin deficiency in organism
The inventive powder is made of ossified horns of reindeer and contains 25 pmol/g of endorphins in the form of agent for preventing and treating pathological states associated with endorphin...
|
|
|
7521069 |
Methods and compositions for pulmonary delivery of insulin
Systemic delivery of insulin to a mammalian host is accomplished by inhalation of a dry powder of insulin. It has been found that dry insulin powders are rapidly absorbed through the alveolar...
|
|
|
7521068 |
Dry powder aerosols of nanoparticulate drugs
There invention discloses aqueous dispersions of nanoparticulate aerosol formulations, dry powder nanoparticulate aerosol formulation, propellant-based aerosol formulations, methods of using the...
|
|
|
7517489 |
Process for making ceramic, mineral, and metal beads from powder
A method is provided for synthesizing beads using starting ceramic, metal, or mineral powders. Typical size of these round beads can range from about 0.1 mm to about 10 mm based on the processing...
|
|
|
7514100 |
Controlled release hydrocodone formulations
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof,...
|
|
|
7514093 |
Vitreous antimicrobial agent and antimicrobial product
A vitreous antimicrobial agent that can exhibit excellent antimicrobial properties when added to various types of resins, that has excellent discoloration resistance and hot water resistance, and...
|
|
|
7514525 |
Recovery and purification of polyhydroxyalkanoates
The present invention relates to a method to recover, purify and isolate polyhydroxyalkanoate (PHA) biopolymers from PHA-containing cell mass, which includes: (a) solubilizing the non-PHA cell mass...
|
|
|
7510702 |
Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
The present invention relates to the delivery of nonsteroidal antiinflammatory drugs (NSAIDs) through an inhalation route. Specifically, it relates to aerosols containing NSAIDs that are used in...
|
|
|
7510727 |
Melt-extrusion multiparticulates
A unit dose sustained-release oral dosage form containing a plurality of melt-extruded particles, each consisting essentially of a therapeutically active agent, one or more retardants, and an...
|
|
|
7507398 |
Delivery of physiologically active compounds through an inhalation route
The present invention relates to the delivery of physiologically active compounds through an inhalation route. Specifically, it relates to aerosols containing physiologically active compounds that...
|
|
|
7507745 |
Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
The present invention relates to novel pharmaceutical compositions based on fluorene carboxylic acid ester derived anticholinergics of formula 1
and soluble TNF receptor fusion proteins,...
|
|
|
7507397 |
Delivery of muscle relaxants through an inhalation route
The present invention relates to the delivery of muscle relaxants through an inhalation route. Specifically, it relates to aerosols containing muscle relaxants that are used in inhalation therapy....
|
|
|
7507254 |
Inorganic bone graft materials using animal bone and method for preparing thereof
The present invention relates to inorganic bone graft materials and a method for preparing the bone graft materials. Particularly, the present invention relates to a method for preparing bone graft...
|
|
|
7504093 |
Composition for treating hair
A hair treatment composition comprises particles having a first non-aqueous phase and, retained within said first non-aqueous phase, a second hydrophilic phase which is an aqueous solution,...
|
|
|
7501134 |
Microparticles with adsorbed polypeptide-containing molecules
Microparticles with absorbed polypeptide-containing molecules formed without the use of surfactant, methods of making such microparticle compositions, and uses thereof, are disclosed. The...
|
|
|
7498019 |
Delivery of compounds for the treatment of headache through an inhalation route
The present invention relates to the delivery of migraine headache drugs through an inhalation route. Specifically, it relates to aerosols containing migraine headache drugs that are used in...
|
|
|
7498020 |
Medicaments
This invention relates to aerosol formulations of use for the administration of medicaments by inhalation, in particular a pharmaceutical aerosol formulation which comprises particulate salbutamol...
|
|
|
7498178 |
Carrier of a diamond fine particle for immobilizing virus
The present invention provides a carrier for immobilizing a bio-derived polymer, and especially, the present invention provides a carrier of diamond fine particle for immobilizing a DNA, RNA,...
|
|
|
7498044 |
Dosage form and method for producing the same
The invention relates to a process for producing a coated drug form or a drug form in the form of an active ingredient matrix, by processing a copolymer, an active pharmaceutical ingredient, a core...
|
|
|
7498043 |
Silicon substituted oxyapatite
The invention is a silicon substituted oxyapatite compound (Si—OAp) for use as a synthetic bone biomaterial either used alone or in biomaterial compositions. The silicon substituted oxyapatite...
|
|
|
7498045 |
Biodegradable polymeric nanocapsules and uses thereof
The present invention relates to a biodegradable polymeric nanocapsule composition, adaptable for encapsulation of an agent of therapeutic interest for enhancing the in vivo circulation time of...
|
|
|
7491047 |
Delivery of antihistamines through an inhalation route
The present invention relates to the delivery of antihistamines through an inhalation route. Specifically, it relates to aerosols containing antihistamines that are used in inhalation therapy. In a...
|
|
|
RE40640 |
Injectable microfoam containing a sclerosing agent
Injectable microfoam for scleroteraphy. The sclerotherapy of varices is based on the injection of liquid substances capable of suppressing them. The present invention relates to the preparation of...
|
|
|
7488469 |
Delivery of caffeine through an inhalation route
The present invention relates to the delivery of caffeine through an inhalation route. Specifically, it relates to aerosols containing caffeine that are used in inhalation therapy. In a composition...
|
|
|
7485319 |
Doxycycline metal complex in a solid dosage form
The present invention is a solid dosage form of a doxycycline metal complex. The present invention also includes a process for making a doxycycline metal complex in a solid dosage form. The process...
|
|
|
7482024 |
Compositions comprising an active agent
The present invention provides a highly dispersible formulation comprising an active agent and a dipeptide or tripeptide comprising at least two leucyl residues. The composition of the invention...
|
|
|
7479254 |
Application using non-covalent bond between a cucurbituril derivative and a ligand
Provided are a kit including a first component that is a compound of formula (1) below bound to a first material and a second component that is a ligand bound to a second material, wherein each of...
|
|
|
7479490 |
Pellet for a presurrized pipeline
A system of equipment allowing addition of solid materials to a pressurized pipeline wherein said solid material is conveyed in such a way as to be readily dissolved by the liquid in said pipeline....
|
|
|
7476380 |
Methods for treating illnesses of the tracheo-bronchial tract, especially chronic obstructive pulmonary disease (COPD)
The invention describes a means for the treatment of diseases of the tracheo-bronchial tract, particularly of COPD.
|
|
|
7476403 |
Oral extended-release composition
The invention is directed to controlled release formulations containing drugs which are preferably considered sparingly soluble to insoluble and which are suitable for administration to a patient...
|
|
|
7476400 |
High-concentration lidocaine compositions and methods for their preparation
A composition comprising lidocaine-containing liposomes wherein the weight concentration of lidocaine in said composition is greater than 10%. The composition is prepared by mixing water with an...
|
|
|
7476694 |
Methods of treating mammals with stabilized particle dispersions containing excipient surface-modified nanoparticles
In one aspect, the invention provides a stable dispersion comprising a continuous phase comprising a continuous liquid phase and a plurality of organic nanoparticles; and a dispersed phase...
|
|
|
7473433 |
Pulmonary delivery of polyene antifungal agents
The present invention provides spray-dried polyene compositions for oral inhalation to the lung. The polyene antifungal compositions demonstrate superior aerosol properties, do not exhibit...
|
|
|
7470437 |
Methods of treating conditions with a metal-containing material
Methods of treating conditions with a metal-containing material are disclosed. The metal-containing material can be, for example, an antimicrobial material, an antibacterial material, an...
|
|
|
7470423 |
Aqueous dispersion containing pyrogenically prepared metal oxide particles and dispersants
An aqueous dispersion containing pyrogenically prepared oxide particles of titanium, zinc, iron or cerium with an average particle size, expressed as the median, in the dispersion of less than 250...
|
|
|
7470436 |
Water-soluble composition containing coenzyme Q10
A water-soluble composition comprising (A) coenzyme Q 10 of 5-40% by weight, (B) monoester of polyglycerol with average polymerization degree of 10 and fatty acid with 18 carbon atoms of 5-30% by...
|
|
|
7470421 |
Delivery of diazepam through an inhalation route
The present invention relates to the delivery of compounds for the treatment of anxiety disorders and symptoms of such disorders through an inhalation route. Specifically, it relates to aerosols...
|